Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
Charlotte, NC
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
Monroe, NC
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
Monroe, NC
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
Raleigh, NC
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
Grove City, OH
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
Grove City, OH
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
Medford, OR
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
Medford, OR
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
Spartanburg, SC
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
El Paso, TX
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
San Antonio, TX
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
mi
from
Vancouver,
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
mi
from
Vancouver,
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated:  8/14/2017
Clinical Research Facility
mi
from
Rolling Hills Estates, CA
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Status: Enrolling
Updated: 8/14/2017
Clinical Research Facility
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
Dietary Intake in Adults From the GA2LEN Folow-up Survey
Dietary Intake, Allergy and Respiratory Diseases in European Adults From the GA2LEN Follow-up Survey
Status: Enrolling
Updated:  8/15/2017
Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Dietary Intake in Adults From the GA2LEN Folow-up Survey
Dietary Intake, Allergy and Respiratory Diseases in European Adults From the GA2LEN Follow-up Survey
Status: Enrolling
Updated: 8/15/2017
Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Exploring a Cessation Intervention for Smokers
Exploring a Cessation Intervention for Low Income Smokers in an Emergency Setting
Status: Enrolling
Updated:  8/29/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Exploring a Cessation Intervention for Smokers
Exploring a Cessation Intervention for Low Income Smokers in an Emergency Setting
Status: Enrolling
Updated: 8/29/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Saint Louis, MO
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Medford, OR
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Orangeburg, SC
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Spartanburg, SC
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Buenos Aires,
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
A Multi-center, Randomized, Double-blind, Dose-ranging Study to Evaluate GSK573719 in Combination With Fluticasone Furoate, Fluticasone Furoate Alone, and an Active Control of Fluticasone Furoate/Vilanterol Combination in Subjects With Asthma
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Buenos Aires,
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Newport Beach, CA
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Upland, CA
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Upland, CA
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Sunset, LA
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Sunset, LA
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Charlotte, NC
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Cincinnati, OH
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Medford, OR
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Gaffney, SC
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Gaffney, SC
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Greenville, SC
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Greenville, SC
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Rock Hill, SC
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Rock Hill, SC
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Spartanburg, SC
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Union, SC
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Union, SC
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Morgantown, WV
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Morgantown, WV
Click here to add this to my saved trials
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated:  9/7/2017
GSK Investigational Site
mi
from
Ciudad Autonoma de Buenos Aires,
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and COPD
Status: Enrolling
Updated: 9/7/2017
GSK Investigational Site
mi
from
Ciudad Autonoma de Buenos Aires,
Click here to add this to my saved trials
Telemedicine Education for Rural Children With Asthma
Telemedicine Education for Rural Children With Asthma
Status: Enrolling
Updated:  9/11/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Telemedicine Education for Rural Children With Asthma
Telemedicine Education for Rural Children With Asthma
Status: Enrolling
Updated: 9/11/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans
A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans
Status: Enrolling
Updated:  9/11/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans
A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans
Status: Enrolling
Updated: 9/11/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
Delta Primary Care Provider (PCP) Survey on Asthma Management
Delta Primary Care Provider (PCP) Survey on Asthma Management
Status: Enrolling
Updated:  9/11/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Delta Primary Care Provider (PCP) Survey on Asthma Management
Delta Primary Care Provider (PCP) Survey on Asthma Management
Status: Enrolling
Updated: 9/11/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
Asthma in the Delta Region of Arkansas: Characterization of Disease and Impact of Environmental Factors
Asthma in the Delta Region of Arkansas: Characterization of Disease and Impact of Environmental Factors
Status: Enrolling
Updated:  9/11/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Asthma in the Delta Region of Arkansas: Characterization of Disease and Impact of Environmental Factors
Asthma in the Delta Region of Arkansas: Characterization of Disease and Impact of Environmental Factors
Status: Enrolling
Updated: 9/11/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers
Glutathione S Transferase M1 (GSTM1) Genotype Associated Susceptibility to Airway Response to Ozone in Mild Asthmatic Volunteers.
Status: Enrolling
Updated:  9/12/2017
Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers
Glutathione S Transferase M1 (GSTM1) Genotype Associated Susceptibility to Airway Response to Ozone in Mild Asthmatic Volunteers.
Status: Enrolling
Updated: 9/12/2017
Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Feasibility of a Clinician Training Program to Improve Patient-provider Communication in the Presence of Health IT Systems in the Exam Room
Feasibility of a Clinician Training Program to Improve Patient-provider Communication in the Presence of Health IT Systems in the Exam Room
Status: Enrolling
Updated:  9/13/2017
Integrated Health Associates ClinSite Research
mi
from
Ann Arbor, MI
Feasibility of a Clinician Training Program to Improve Patient-provider Communication in the Presence of Health IT Systems in the Exam Room
Feasibility of a Clinician Training Program to Improve Patient-provider Communication in the Presence of Health IT Systems in the Exam Room
Status: Enrolling
Updated: 9/13/2017
Integrated Health Associates ClinSite Research
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
T Cell Effector and Regulatory Mechanisms in Asthma
T Cell Effector and Regulatory Mechanisms in Asthma
Status: Enrolling
Updated:  9/14/2017
Massachusetts General Hospital
mi
from
Boston, MA
T Cell Effector and Regulatory Mechanisms in Asthma
T Cell Effector and Regulatory Mechanisms in Asthma
Status: Enrolling
Updated: 9/14/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
Status: Enrolling
Updated:  9/14/2017
Massachusetts General Hospital
mi
from
Boston, MA
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
Status: Enrolling
Updated: 9/14/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated:  9/14/2017
GSK Investigational Site
mi
from
Denver, CO
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated: 9/14/2017
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated:  9/14/2017
GSK Investigational Site
mi
from
Baltimore, MD
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated: 9/14/2017
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated:  9/14/2017
GSK Investigational Site
mi
from
Orangeburg, SC
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated: 9/14/2017
GSK Investigational Site
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated:  9/14/2017
GSK Investigational Site
mi
from
Huntington Beach, CA
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated: 9/14/2017
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated:  9/14/2017
GSK Investigational Site
mi
from
Mission Viejo, CA
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated: 9/14/2017
GSK Investigational Site
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated:  9/14/2017
GSK Investigational Site
mi
from
San Diego, CA
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated: 9/14/2017
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated:  9/14/2017
GSK Investigational Site
mi
from
Tallahassee, FL
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated: 9/14/2017
GSK Investigational Site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated:  9/14/2017
GSK Investigational Site
mi
from
Savannah, GA
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated: 9/14/2017
GSK Investigational Site
mi
from
Savannah, GA
Click here to add this to my saved trials
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated:  9/14/2017
GSK Investigational Site
mi
from
Raleigh, NC
Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult Subjects With Asthma and Exercise-Induced Bronchoconstriction
Status: Enrolling
Updated: 9/14/2017
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials